Dutch firm Molecular Biology Systems validating rapid thermal cycler for COVID-19 testing

Press/Media: ResearchAcademic

Description

Dutch company Molecular Biology Systems is in the process of validating its shoebox-sized NextGenPCR instrument for rapid SARS-CoV-2 diagnostic testing, claiming the system could potentially process more than 22,000 samples in a day by performing plate-based thermal cycling in less than eight minutes.

....................

In addition, in a research evaluation of the NextGenPCR instrument published in The Journal of Microbiological Methods in February, a group at The University of Groningen found equivalent sensitivity compared to a standard thermal cycler, the Eppendorf Mastercycler Nexus PCR instrument.

Period22-Apr-2020

Media coverage

1

Media coverage

  • TitleDutch firm Molecular Biology Systems validating rapid thermal cycler for COVID-19 testing
    Degree of recognitionInternational
    Media name/outletGenomeWeb
    Media typeWeb
    CountryUnited States
    Date22/04/2020
    DescriptionDutch company Molecular Biology Systems is in the process of validating its shoebox-sized NextGenPCR instrument for rapid SARS-CoV-2 diagnostic testing, claiming the system could potentially process more than 22,000 samples in a day by performing plate-based thermal cycling in less than eight minutes.

    ....................

    In addition, in a research evaluation of the NextGenPCR instrument published in The Journal of Microbiological Methods in February, a group at The University of Groningen found equivalent sensitivity compared to a standard thermal cycler, the Eppendorf Mastercycler Nexus PCR instrument.
    Producer/AuthorMadeleine Johnson
    URLhttps://www.genomeweb.com/pcr/dutch-firm-molecular-biology-systems-validating-rapid-thermal-cycler-covid-19-testing
    PersonsJolanda Brons, Marjon de Vos, Stefanie Vink, Jan Dirk van Elsas